ddrg/super_eurlex huggingface dataset:
Non-opposition to a notified concentration

(Case M.9840 – Macquarie/Fresco International)

(Text with EEA relevance)

(2020/C 227/02)

On 11 May 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9840. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9826 – Mitsubishi Chemical Holdings/UBE Industries/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 221/05)

1. On 25 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Mitsubishi Chemical Holdings Corporation (‘MCHC’, Japan), — Ube Industries, Ltd (‘Ube’, Japan), — JV (Japan). MCHC and Ube acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of the JV. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — MCHC: global Japanese chemical manufacturing company, active in performance products, industrial materials, and health care applications, including electrolytes for lithium-ion secondary batteries (‘LIBs’), — Ube: global Japanese company, active in three main business segments: chemicals, construction materials and machinery, — JV: will combine the activities of MCHC and Ube in the production and sale of electrolytes for LIBs, and will carry out the production and sale of electrolytes for LIBs globally.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9826 – Mitsubishi Chemical Holdings/UBE Industries/JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9787 — Česká Spořitelna/Československá Obchodní Banka/Komerční Banka/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 238/05)

1. On 10 July 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Česká spořitelna, a.s. (CS, Czechia), belonging to Erste Group Bank AG (Austria), — Československá obchodní banka, a.s. (ČSOB, Czechia), belonging to KBC Group (Belgium), — Komerční banka, a.s. (KB, Czechia), belonging to Société Générale Group (France). CS, ČSOB an KB acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly created company constituting a joint venture (the ‘JV’, Czechia). The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — CS: is a banking company operating in Czechia, which provides banking and financial services to individuals, small and medium enterprises, municipalities and other public sector entities and also to multinational corporations and financial institutions, — ČSOB: is a banking company operating in Czechia. ČSOB offers banking products and services to all groups of clients, i.e., individuals, SMEs and to corporate and institutional clients, — KB: is a banking company operating in Czechia and in the EEA, which provides a wide range of services in retail, corporate and investment banking, — The JV will provide e-identification services in Czechia.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9787 — Česká Spořitelna/Československá Obchodní Banka/Komerční Banka/JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: E-mail: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.9802 – Liberty Global/DPG Media/JV)

(Text with EEA relevance)

(2020/C 233/04)

1. On 7 July 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Liberty Global plc (United Kingdom, ‘Liberty Global’), through its affiliates Telenet Group NV and Telenet BV (Belgium, together ‘Telenet’), — DPG Media NV (Belgium, ‘DPG Media’), — the Joint Venture (Belgium, ‘JV’). Liberty Global and DPG Media acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of the JV. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — for Liberty Global: through its subsidiary Telenet, the operation of cable and mobile networks in Belgium and parts of Luxembourg, specialising in (i) the supply of broadband internet, fixed telephony services and cable television primarily in Flanders and parts of Brussels; (ii) the supply of mobile telecommunications services in the whole of Belgium; (iii) the operation of Dutch-language pay TV channels and video-on-demand services (Play, Play More and Play Sports), free-to-air TV channels (Vier, Vijf, Zes); and (iv) the operation of the production company Woestijnvis, — for DPG Media: (i) the supply of Dutch-language daily newspapers (Het Laatste Nieuws, De Morgen) and magazines (e.g. Dag Allemaal, Goed Gevoel, Humo); (ii) the operation of TV channels (VTM, Q2, Vitaya, CAZ, and VTM Kids), an advertising-based video on demand service (VTM Go) and radio stations (Q-music and Joe); and (iii) the operation of a telecom mobile virtual network (Mobile Vikings), — for the JV: the supply of a subscription-video-on-demand offering under a new and independent brand in Belgium focused on Dutch-speaking consumers.The JV’s offering will primarily consist of local and international films and series. It will neither include (i) sports or adult content; nor (ii) linear channels (of Telenet and/or DPG Media and/or of third parties) and ancillary services linked thereto (e.g. catch-up services).

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9802 – Liberty Global/DPG Media/JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Official Journal of the European Union

Prior notification of a concentration

(Case M.9877 – Pro Diagnostic Group/FutureLife/DISCARE CZ JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 261/02)

1. On 3 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Pro Diagnostic Group, a.s (‘PDG’, Slovakia), controlled by Ribera Salud Infraestructuras, S.L.U. (Spain) and Pro Partners Holding, a.s. (Slovakia); — FutureLife a.s. (‘FutureLife’, Czechia), ultimately controlled by Mr. Zbyněk Průša; — DISCARE a.s. (‘JV’, Czechia), currently solely controlled by PDG. PDG and FutureLife acquire within the meaning of Articles 3(1)(b) and 3(4) of the Merger Regulation joint control of the JV. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — for PDG: it operates 12 diagnostic imaging centres in private health facilities in Slovakia in the Magnetic Resonance Imaging (‘MRI’), X-Ray (‘RTG’), Computed Tomography (‘CT’)/ Positron Emission Tomography (‘PET’) and Ultrasonography (‘USG’) modalities; — for FutureLife: active in the provision of healthcare services and laboratories. The FutureLife group companies mainly operate healthcare clinics providing services in the field of assisted reproduction in central Europe. Some group companies also operate outpatient and inpatient clinics specialized in medical care in areas such as rheumatology, andrology, venous surgery, gastroenterology, urology, treatment of Crohn’s disease and other inflammatory bowel diseases, and plastic surgery; — for the JV: it will operate a diagnostic imaging centre in the RTG and MRI modalities in Prague.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004, (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9877 – Pro Diagnostic Group/FutureLife/DISCARE CZ JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9826 –Mitsubishi Chemical Holdings/UBE Industries/JV)

(Text with EEA relevance)

(2020/C 250/03)

On 20 July 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9826. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9874 — Tokyo Century Corporation/Nippon Telegraph and Telephone Corporation/JV)

(Text with EEA relevance)

(2020/C 274/02)

On 6 July 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9874. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Initiation of proceedings

(Case M.9660 – Google/Fitbit)

(Text with EEA relevance)

(2020/C 268/03)

On 4 August 2020, the Commission decided to initiate proceedings in the abovementioned case after finding that the notified concentration raises serious doubts as to its compatibility with the internal market. The initiation of proceedings opens a second phase investigation with regard to the notified concentration, and is without prejudice to the final decision on the case. The decision is based on Article 6(1)(c) of Council Regulation (EC) No 139/2004 (1).

The Commission invites interested third parties to submit their observations on the proposed concentration to the Commission.

In order to be fully taken into account in the procedure, observations should reach the Commission not later than 15 days following the date of this publication. Observations can be sent to the Commission by fax (+ 32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference M.9660 – Google/Fitbit, to the following address:

European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Official Journal of the European Union

Prior notification of a concentration

(Case M.9910 – Mapfre Group/Santander Group/Popular Seguros JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 289/02)

1. On 21 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Mapfre S.A., and its subsidiaries (‘Mapfre Group’, Spain), — Banco Santander, S.A., and its subsidiaries (‘Santander Group’, Spain), — Popular Seguros – Companhia de Seguros, S.A. (‘Popular JV’, Portugal), controlled by the Santander Group. Mapfre Group and Santander Group acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Popular JV. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Mapfre Group: insurance and reinsurance activities across 45 countries, including Portugal, Spain and other countries in Europe and worldwide, — for Santander Group: retail banking, corporate banking, investment banking, asset management and treasury across Europe, as well as in the United States, Latin America and Asia, — for Popular JV: the provision of non-life insurance in Portugal.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9910 – Mapfre Group/Santander Group/Popular Seguros JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: E-mail: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 229-64301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.9930 – LGP/TPG/WellSky)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 280/09)

1. On 18 August 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Leonard Green & Partners, L.P. (‘LGP’, USA), — TPG Capital (‘TPG’, USA), — WellSky Corporation (‘WellSky’, USA). LPG and TPG will acquire joint control within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation over the whole of WellSky. TPG currently enjoys sole control over WellSky. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for LGP: private equity investment firm, primarily investing in companies providing services, including consumer, business, and healthcare services, as well as retail, distribution, and industrials, — for TPG: private investment firm that manages a family of funds that invest in a variety of companies through acquisitions and corporate restructurings, — for WellSky: provider of specialty healthcare software (Software as a Service, ‘SaaS’ and other software platforms) for managing clinical, financial and administrative work flows. In the EEA, WellSky only markets software solutions, which address medication management and chemotherapy management software.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9930 – LGP/TPG/WellSky Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.9906 – KKR/HPS/Monleasing Holdco)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 300/07)

1. On 2 September 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — KKR & Co. Inc. (‘KKR’ United States), — HPS Investment Partners, LLC (‘HPS’, United States), — Monleasing Holdco Pty Ltd (‘Monleasing’, Australia) KKR and HPS acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Monleasing from Monash Private Capital Pty Ltd. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for KKR: global investment firm, which offers a broad range of alternative asset funds and other investment products to investors and provides capital markets solutions for the firm, its portfolio companies and other clients, — for HPS: US-based investment firm that focuses on acquisitions and strategic financing or recapitalisation of companies that require financial assistance, — for Monleasing: active in the commercial and industrial equipment rental and leasing industry exclusively in Australia and New Zealand.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9906 – KKR/HPS/Monleasing Holdco Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.